{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:12:34Z","timestamp":1791828754085,"version":"4.3.4"},"reference-count":248,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.abd.2020.08.001","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T08:07:51Z","timestamp":1602317271000},"page":"53-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"S1","title":["Consensus on the therapeutic management of rosacea \u2013 Brazilian Society of Dermatology"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0406-360X","authenticated-orcid":false,"given":"Clivia Maria Moraes de","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7210-021X","authenticated-orcid":false,"given":"Luiz Mauricio Costa","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4792-8466","authenticated-orcid":false,"given":"Renan Rangel","family":"Bonamigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7067-229X","authenticated-orcid":false,"given":"Carla Wanderley Gayoso de","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-8241","authenticated-orcid":false,"given":"Edil\u00e9ia","family":"Bagatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2020.08.001_bib0005","first-page":"282","article-title":"Incidence and prevalence of rosacea: a systematic review and meta-analysis","volume":"179","author":"Gether","year":"2018","journal-title":"Br J Dermatol"},{"issue":"F1000 Faculty Rev","key":"10.1016\/j.abd.2020.08.001_bib0010","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.12688\/f1000research.16537.1","article-title":"Recent advances in understanding and managing ros\u00e1cea","volume":"7","author":"Buddenkotte","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.abd.2020.08.001_bib0015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/ijd.13491","article-title":"Epidemiology of rosacea in Colombia","volume":"56","author":"Rueda","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0020","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/1346-8138.14281","article-title":"Epidemiological and clinical features of rosacea in Korea: a multicenter cross-sectional study","volume":"45","author":"Lee","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0025","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.jaad.2018.08.049","article-title":"Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: review and clinical practice experience","volume":"80","author":"Alexis","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1590\/S0365-05962008000500004","article-title":"Factors associated with rosacea in population samples of Southern Brazil: analysis of case-control studies","volume":"83","author":"Bonamigo","year":"2008","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0035","doi-asserted-by":"crossref","first-page":"e1361574","DOI":"10.1080\/19381980.2017.1361574","article-title":"Rosacea: epidemiology, pathogenesis, and treatment","volume":"9","author":"Rainer","year":"2017","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.abd.2020.08.001_bib0040","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.4081\/dr.2016.6387","article-title":"Rosacea: a clinical review","volume":"8","author":"Mikkelsen","year":"2016","journal-title":"Dermatology Reports"},{"key":"10.1016\/j.abd.2020.08.001_bib0045","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/jdv.13556","article-title":"Prevalence of rosacea in the general population of Germany and Russia \u2013 The RISE study","volume":"30","author":"Tan","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib0050","first-page":"419","article-title":"An epidemiological study of rosacea","volume":"69","author":"Berg","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.det.2017.11.006","article-title":"Rosacea Comorbidities","volume":"36","author":"Vera","year":"2018","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2020.08.001_bib0060","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","article-title":"Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors","volume":"72","author":"Two","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0065","first-page":"469402","article-title":"Assessment of Tachykinin receptor 3\u2019 gene polymorphism rs3733631 in Rosacea","author":"Karpouzis","year":"2015","journal-title":"Int Sch Res Notices. 2015"},{"key":"10.1016\/j.abd.2020.08.001_bib0070","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0781.2006.00220.x","article-title":"GSTM1 and GSTT1 null genotypes as possible heritable factors of rosacea","volume":"22","author":"Yazici","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.abd.2020.08.001_bib0075","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jamadermatol.2015.2230","article-title":"Genetic vs environmental factors that correlate with rosacea: a cohort-based survey of twins","volume":"151","author":"Aldrich","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0080","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/jid.2015.53","article-title":"Assessment of the genetic basis of rosacea by genome-wide association study","volume":"135","author":"Chang","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0085","series-title":"Dermatology in public health environments","first-page":"465","article-title":"Rosacea","author":"Bonamigo","year":"2018"},{"key":"10.1016\/j.abd.2020.08.001_bib0090","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1600-0625.2008.00753.x","article-title":"Granulomatous rosacea and Crohn's disease in a patient homozygous for the Crohn-associated NOD2\/CARD15 polymorphism R702W","volume":"17","author":"Van Steensel","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0095","first-page":"20","article-title":"Kallikrein 5-mediated inflammation in rosacea: clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefit","volume":"7","author":"Two","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0100","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3349\/ymj.2014.55.6.1648","article-title":"Increased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea","volume":"55","author":"Kim","year":"2014","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.abd.2020.08.001_bib0105","first-page":"1548","article-title":"Increased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea","volume":"135","author":"Kim","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0110","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1468-3083.2005.01221.x","article-title":"Could matrix metalloproteinase-9 be a link between Demodex folliculorum and rosacea?","volume":"19","author":"Bonamigo","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib0115","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1365-2133.2004.05985.x","article-title":"Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis","volume":"150","author":"Dirschka","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/bjd.12770","article-title":"Epidermal hydration levels in patients with rosacea improve after minocycline therapy","volume":"171","author":"N\u00ed Raghallaigh","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-3083.2011.04310.x","article-title":"Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link","volume":"26","author":"Forton","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/jidsymp.2011.9","article-title":"Rosacea: the cytokine and chemokine network","volume":"15","author":"Gerber","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.abd.2020.08.001_bib0135","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2015.141","article-title":"Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1\/Th17 pathways","volume":"135","author":"Buhl","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/15569527.2013.797907","article-title":"Vitamin D status in patients with rosacea","volume":"33","author":"Ekiz","year":"2014","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.abd.2020.08.001_bib0145","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/jid.2009.435","article-title":"Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid","volume":"130","author":"Morizane","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0150","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/exd.12745","article-title":"Recombinant erythroid differentiation regulator 1 inhibits both inflammation and angiogenesis in a mouse model of rosacea","volume":"24","author":"Kim","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0155","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.2353\/ajpath.2010.090941","article-title":"Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo","volume":"177","author":"Seeliger","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.abd.2020.08.001_bib0160","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.177.5.1269","article-title":"Functional neurokinin 1 receptors for substance P are expressed by human vascular endothelium","volume":"177","author":"Greeno","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.abd.2020.08.001_bib0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/abd1806-4841.20163541","article-title":"Skin barrier in rosacea","volume":"91","author":"Addor","year":"2016","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0170","unstructured":"rosacea.org [Internet]. New survey pinpoints leading factors that trigger symptoms. [cited 05.14.20] Available from: http:\/\/www.rosacea.org\/rr\/2002\/summer\/article_3.php."},{"key":"10.1016\/j.abd.2020.08.001_bib0175","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/exd.13143","article-title":"Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics","volume":"26","author":"Holmes","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0180","unstructured":"rosacea.org [Internet]. Survey shows lifestyle changes help control rosacea flare-ups. [cited 05.15.20] Available from: http:\/\/www.rosacea.org\/rr\/1998\/winter\/article_3.php."},{"key":"10.1016\/j.abd.2020.08.001_bib0185","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0190","first-page":"907","article-title":"Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea","volume":"50","author":"Wilkin","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0195","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2017.08.037","article-title":"Standard classification and pathophysiology of ros\u00e1cea: the 2017 update by the National Rosacea Society Expert Committee","volume":"78","author":"Gallo","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0200","first-page":"159","article-title":"Update on the management of rosacea","volume":"8","author":"Weinkle","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0205","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12385","article-title":"An observational cross- sectional survey of rosacea: clinical associations and progression between subtypes","volume":"169","author":"Tan","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0210","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/bjd.15122","article-title":"Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel","volume":"176","author":"Tan","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0215","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.jaad.2018.08.049","article-title":"Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: review and clinical practice experience","volume":"80","author":"Alexis","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0220","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0001-7310(08)74672-6","article-title":"Ros\u00e1cea","volume":"99","author":"Barco","year":"2008","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.abd.2020.08.001_bib0225","first-page":"7","article-title":"Actualizaci\u00f3n y recomendaciones para el diagn\u00f3stico y tratamiento de la ros\u00e1cea en Latinoam\u00e9rica","volume":"44","author":"Troielli","year":"2016","journal-title":"Med Cutan Iber Lat Am"},{"key":"10.1016\/j.abd.2020.08.001_bib0230","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jidsymp.2011.6","article-title":"Neurovascular and neuroimmune aspects in the pathophysiology of rosacea","volume":"15","author":"Schwab","year":"2011","journal-title":"J Invest Dermatol Symp Proc"},{"key":"10.1016\/j.abd.2020.08.001_bib0235","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","article-title":"Clinical, cellular, and molecular aspects in the pathophysiology of rosacea","volume":"15","author":"Steinhoff","year":"2011","journal-title":"J Invest Dermatol Symp Proc"},{"key":"10.1016\/j.abd.2020.08.001_bib0240","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.jid.5700213","article-title":"Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling","volume":"126","author":"Trivedi","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0245","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2015.141","article-title":"Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1\/Th17 pathways","volume":"135","author":"Buhl","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0250","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/000155599750009915","article-title":"Stinging and rosacea","volume":"79","author":"Lonne-Rahm","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib0255","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1152\/physrev.00031.2013","article-title":"Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease","volume":"94","author":"Steinhoff","year":"2014","journal-title":"Physiol Rev"},{"key":"10.1016\/j.abd.2020.08.001_bib0260","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/bjd.18420","article-title":"Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel","volume":"182","author":"Schaller","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0265","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2133.2010.09894.x","article-title":"The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities","volume":"163","author":"Aksoy","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0270","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1468-3083.2005.01216.x","article-title":"Rosacea and its management: an overview","volume":"19","author":"Gupta","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib0275","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaad.2006.04.084","article-title":"Systematic review of rosacea treatments","volume":"56","author":"van Zuuren","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0280","first-page":"2403","article-title":"Interventions for rosacea","volume":"314","author":"van Zuuren","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0285","first-page":"CD003262","article-title":"Interventions for rosacea","author":"van Zuuren","year":"2015","journal-title":"Cochrane Database Syst Rev. 2015"},{"key":"10.1016\/j.abd.2020.08.001_bib0290","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMcp1506630","article-title":"Rosacea","volume":"377","author":"van Zuuren","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.abd.2020.08.001_bib0295","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bjd.17590","article-title":"Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments","volume":"181","author":"van Zuuren","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0300","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/ijms19010070","article-title":"Anti-Inflammatory and skin barrier repair effects of topical application of some plant oils","volume":"19","author":"Lin","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.abd.2020.08.001_bib0305","first-page":"11","article-title":"A novel night moisturizer enhances cutaneous barrier function in dry skin and improves dermatological outcomes in rosacea-prone skin","volume":"11","author":"Santoro","year":"2018","journal-title":"J Clin Aesth Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0310","first-page":"26","article-title":"Rosacea, reactive oxygen species, and azelaic acid","volume":"2","author":"Jones","year":"2009","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0315","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000354888","article-title":"Azelaic acid: properties and mode of action","volume":"27","author":"Sieber","year":"2014","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.abd.2020.08.001_bib0320","doi-asserted-by":"crossref","first-page":"e1361570","DOI":"10.1080\/19381980.2017.1361570","article-title":"Modulation of Toll Like Receptor-2 on sebaceous gland by the treatment of adult female acne","volume":"9","author":"Rocha","year":"2017","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.abd.2020.08.001_bib0325","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mjd.2003.308","article-title":"Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies","volume":"48","author":"Thiboutot","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0330","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/archderm.142.8.1047","article-title":"Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials","volume":"142","author":"Liu","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0335","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaad.2013.06.009","article-title":"Management of facial erythema of rosacea: what is the role of topical \u03b1-adrenergic receptor agonist therapy?","volume":"69","author":"Del Rosso","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0340","first-page":"28","article-title":"Topical a-agonist therapy for persistent facial erythema of rosacea and the addition of oxymetazoline to the treatment armamentarium: where are we now","volume":"10","author":"Del Rosso","year":"2017","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0345","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jaad.2018.01.027","article-title":"Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 52-week open label REVEAL trial","volume":"78","author":"Draelos","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0350","first-page":"39","article-title":"Topical ivermectin: data supporting dual modes of action in rosacea","volume":"10","author":"Del Rosso","year":"2017","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0355","first-page":"1","article-title":"Efficacy of topical ivermectin for the treatment of cutaneous and ocular rosacea","volume":"7","author":"Sobolewska","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.abd.2020.08.001_bib0360","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/jdv.14885","article-title":"Papulopustular rosacea and rosacea-like demodicosis: two phenotypes of the same disease?","volume":"32","author":"Forton","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib0365","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/bjd.13408","article-title":"Superiority of ivermectin 1% cream over metronidazole 0.75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial","volume":"172","author":"Taieb","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0370","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s13555-018-0249-y","article-title":"Topical ivermectin in the treatment of papulopustular rosacea: a systematic review of evidence and clinical guideline recommendation","volume":"8","author":"Ebbelaar","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.abd.2020.08.001_bib0375","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/archdermatol.2011.204","article-title":"Carvedilol for the treatment of refractory facial flushing and persistent erythema of rosacea","volume":"147","author":"Hsu","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0380","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000368773","article-title":"Botulinum toxin for the treatment of refractory erythema and flushing of rosacea","volume":"230","author":"Park","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.abd.2020.08.001_bib0385","first-page":"121","article-title":"Prospective study for the treatment of rosacea flushing with botulinum toxin type A Estudo prospectivo para tratamento do rubor da ros\u00e1cea com toxina botul\u00ednica tipo A","volume":"10","author":"Silva","year":"2018","journal-title":"Surg Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0390","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/14764172.2011.613480","article-title":"Intense pulsed light for the treatment of rosacea and telangiectasias","volume":"13","author":"Kassir","year":"2011","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.abd.2020.08.001_bib0395","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2004.03.033","article-title":"Rosacea: II. Therapy","volume":"51","author":"Pelle","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0400","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1586\/17469872.2.5.523","article-title":"Anti-inflammatory dose doxycycline for the treatment of rosacea","volume":"6","author":"Fowler","year":"2007","journal-title":"Expert Rev Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0405","first-page":"641","article-title":"Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea","volume":"6","author":"Fowler","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0410","first-page":"573","article-title":"Comparison of anti-inflammatory dose doxycycline versus doxycycline 100mg in the treatment of rosacea","volume":"7","author":"Del Rosso","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0415","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s12325-016-0380-z","article-title":"Topical Ivermectin 10mg\/g and Oral Doxycycline 40mg modified-release: current evidence on the complementary use of anti-inflammatory rosacea treatments","volume":"33","author":"Steinhoff","year":"2016","journal-title":"Adv Ther"},{"key":"10.1016\/j.abd.2020.08.001_bib0420","first-page":"22","article-title":"Updated physician's guide to the off-label uses of oral isotretinoin","volume":"7","author":"Nickle","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0425","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/jid.2010.351","article-title":"TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes","volume":"131","author":"Yamasaki","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0430","first-page":"177","article-title":"Severe rosacea treated with oral isotretinoin","volume":"122","author":"Gajardo","year":"1994","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.abd.2020.08.001_bib0435","first-page":"505","article-title":"Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study","volume":"8","author":"Gollnick","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.abd.2020.08.001_bib0440","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2230.2004.01472.x","article-title":"Continuous \u201cmicrodose\u201d isotretinoin in adult recalcitrant rosacea","volume":"29","author":"Hofer","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0445","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2340\/00015555-1204","article-title":"Rosacea treatment with intermediate-dose isotretinoin: follow-up with erythema and sebum measurements","volume":"92","author":"Uslu","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib0450","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40257-017-0310-0","article-title":"Diagnosis and treatment of rosacea fulminans: a comprehensive review","volume":"19","author":"Walsh","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0455","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaad.2010.06.040","article-title":"Effective monitoring of isotretinoin safety in a pediatric dermatology population: a novel \u201cpatient symptom survey\u201d approach","volume":"65","author":"Hodgkiss-Harlow","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0460","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00403-006-0638-4","article-title":"Effects of isotretinoin on the metabolism of triglyceride-rich lipoproteins and on the lipid profile in patients with acne","volume":"297","author":"De Marchi","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.abd.2020.08.001_bib0465","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jid.2016.01.025","article-title":"A randomized-controlled trial of oral low-dose isotretinoin for difficult-to-treat papulopustular rosacea","volume":"136","author":"Sbidian","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0470","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.sder.2008.03.005","article-title":"Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review","volume":"26","author":"Marqueling","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0475","doi-asserted-by":"crossref","first-page":"e021549","DOI":"10.1136\/bmjopen-2018-021549","article-title":"Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis","volume":"9","author":"Li","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.abd.2020.08.001_bib0480","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1038\/ajg.2009.417","article-title":"Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study","volume":"104","author":"Bernstein","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.abd.2020.08.001_bib0485","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/ajg.2010.124","article-title":"Isotretinoin use and the risk of inflammatory bowel disease: a case-control study","volume":"105","author":"Crockett","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.abd.2020.08.001_bib0490","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000057887","article-title":"A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgaris","volume":"204","author":"Altman","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.abd.2020.08.001_bib0495","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.7241\/ourd.2017.10.2017","article-title":"Systemic isotretinoin treatment and pregnancy: a comparative study of two groups of women: a retrospective analysis of 569 women","volume":"9","author":"Brzezinski","year":"2017","journal-title":"Our Dermatol Online"},{"key":"10.1016\/j.abd.2020.08.001_bib0500","doi-asserted-by":"crossref","first-page":"377","DOI":"10.15171\/apb.2018.044","article-title":"Isotretinoin: a review on the utilization pattern in pregnancy","volume":"8","author":"Khiali","year":"2018","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.abd.2020.08.001_bib0505","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1468-3083.2009.03167.x","article-title":"Current topical and systemic approaches to treatment of rosacea","volume":"23","author":"Korting","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib0510","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/ajd.12505","article-title":"Phymatous rosacea presenting with leonine facies and clinical response to isotretinoin","volume":"58","author":"Wee","year":"2017","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0515","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaad.2013.04.040","article-title":"Ocular rosacea: a dermatologic perspective","volume":"69","author":"Webster","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0520","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.det.2015.03.009","article-title":"Granulomatous rosacea and periorificial dermatitis: controversies and review of management and treatment","volume":"33","author":"Lee","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2020.08.001_bib0525","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2340\/00015555-2335","article-title":"Facial erythema of rosacea \u2013 aetiology, different pathophysiologies and treatment options","volume":"96","author":"Steinhoff","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib0530","first-page":"71","article-title":"Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 4: a status report on physical modalities and devices","volume":"93","author":"Tanghetti","year":"2014","journal-title":"Cutis"},{"key":"10.1016\/j.abd.2020.08.001_bib0535","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/1346-8138.14513","article-title":"Successful treatment of erythematotelangiectatic rosacea with intense pulsed light: report of 13 cases Kanako","volume":"45","author":"Tsunoda","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0540","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1468-3083.2010.03751.x","article-title":"Rosacea \u2013 global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group","volume":"25","author":"Elewski","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib0545","first-page":"134","article-title":"Consensus recommendations from the American Acne & Rosacea society on the management of rosacea, part 5: a guide on the management of rosacea","volume":"93","author":"Del Rosso","year":"2014","journal-title":"Cutis"},{"key":"10.1016\/j.abd.2020.08.001_bib0550","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1524-4725.2009.01156.x","article-title":"Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic ros\u00e1cea","volume":"35","author":"Neuhaus","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0555","series-title":"Manual Pr\u00e1tico do Laser e Outras Fontes de Energia Eletromagn\u00e9tica na Dermatologia","author":"Kalil","year":"2017"},{"key":"10.1016\/j.abd.2020.08.001_bib0560","first-page":"e76","article-title":"A new treatment regimen for rosacea: onabotulinumtoxin A","volume":"11","author":"Dayan","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0565","first-page":"37","article-title":"Successful treatment of erythematotelangiectatic rosacea with pulsed light and radiofrequency","volume":"1","author":"Taub","year":"2008","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0570","first-page":"159","article-title":"Update on the management of rosacea","volume":"8","author":"Weinkle","year":"2015","journal-title":"Clinical, Cosmetic and Investigational Dermatology"},{"key":"10.1016\/j.abd.2020.08.001_bib0575","first-page":"17","article-title":"Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS)","volume":"12","author":"Del Rosso","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0580","first-page":"673","article-title":"Rosacea: a review of current topical, systemic and light-based therapies","volume":"144","author":"Kennedy Carney","year":"2009","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib0585","first-page":"725","article-title":"Diagnosis and treatment of rosacea: state of the art","volume":"11","author":"Baldwin","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0590","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10103-002-8263-8","article-title":"Laser treatment of erythema and telangiectasia associated with rosacea","volume":"17","author":"Clark","year":"2002","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.abd.2020.08.001_bib0595","first-page":"600","article-title":"Objective and quantitative improvement of rosacea-associated erythema after intense pulsed light treatment","volume":"29","author":"Mark","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0600","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaad.2015.05.030","article-title":"Efficacy of the long-pulsed 1064-nm neodymium: yttrium-aluminum-garnet laser (LPND) (rejuvenation mode) in the treatment of papulopustular rosacea (PPR): a pilot study of clinical outcomes and patient satisfaction in 30 cases","volume":"73","author":"Lee","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0605","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0151-9638(11)70094-1","article-title":"Prise em charge par laser et lampes puls\u00e9es de la couperose et de la rosac\u00e9e laser and intense pulsed light managemenr of couperose and ros\u00e1cea","volume":"138","author":"Dahan","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib0610","first-page":"9","article-title":"Luz intensa pulsada: revis\u00e3o das indica\u00e7\u00f5es cl\u00ednicas","volume":"9","author":"Kalil","year":"2017","journal-title":"Surg Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0615","first-page":"557","article-title":"The pulse-dyed laser for the treatment of cutaneous conditions","volume":"144","author":"Bernstein","year":"2009","journal-title":"G Ital Dermatol Venerol"},{"key":"10.1016\/j.abd.2020.08.001_bib0620","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.6836297","article-title":"Selective photothermolysis: precise microsurgery by selective absorption of radiation","volume":"220","author":"Anderson","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.abd.2020.08.001_bib0625","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/jocd.12724","article-title":"The new therapeutic choice of tranexamic acid solution in treatment of erythematotelangiectatic rosacea","volume":"18","author":"Bageorgou","year":"2019","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0630","first-page":"110","article-title":"Microneedling experimental study and classification of the resulting injury","volume":"5","author":"Lima","year":"2013","journal-title":"Surg Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0635","first-page":"211","article-title":"Comparative, randomized, double-blind study of microneedling associated with drug delivery for rejuvenating the skin of the anterior thorax region","volume":"7","author":"Kalil","year":"2015","journal-title":"Surg Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0640","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/dth.12439","article-title":"Combination treatment of propranolol, minocycline, and tranexamic acid for effective control of rosacea","volume":"30","author":"Kwon","year":"2017","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.abd.2020.08.001_bib0645","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/lsm.20273","article-title":"The effects of pulse dye laser double-pass treatment intervals on depth of vessel coagulation","volume":"38","author":"Tanghetti","year":"2006","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.abd.2020.08.001_bib0650","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1529-8019.2012.01463.x","article-title":"Laser use for cutaneous vascular alterations of cosmetic interest","volume":"25","author":"Bencini","year":"2012","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.abd.2020.08.001_bib0655","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/00042728-200510000-00004","article-title":"Effective treatment of rosacea using intense pulsed light systems","volume":"31","author":"Schroeter","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0660","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/lsm.21151","article-title":"Split-face randomized treatment of facial telangiectasia comparing pulsed dye laser and an intense pulsed light handpiece","volume":"44","author":"Tanghetti","year":"2011","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.abd.2020.08.001_bib0665","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000446215","article-title":"Rosacea Management","volume":"2","author":"Abokwidir","year":"2016","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.abd.2020.08.001_bib0670","first-page":"1","article-title":"Efic\u00e1cia comparativa de luz intensa pulsada para diferentes eritemas associados com ros\u00e1cea","volume":"25","author":"Liu","year":"2014","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.abd.2020.08.001_bib0675","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/dsu.12424","article-title":"Application of intense pulsed light in the treatment of dermatologic disease: a systematic review","volume":"40","author":"Wat","year":"2014","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0680","doi-asserted-by":"crossref","first-page":"491","DOI":"10.5021\/ad.2014.26.4.491","article-title":"The Efficacy of Intense Pulsed Light for Treating Erythematotelangiectatic Rosacea Is Related to Severity and Age","volume":"26","author":"Lim","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0685","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/jocd.12903","article-title":"Global rosacea treatment guidelines and expert consensus points: the differences","volume":"18","author":"Juliandri","year":"2019","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0690","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1524-4725.2010.01503.x","article-title":"Use of intense pulsed light to treat refractory granulomatous rosacea","volume":"36","author":"Lane","year":"2010","journal-title":"Dermatologic Surgery"},{"key":"10.1016\/j.abd.2020.08.001_bib0695","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2133.2008.08702.x","article-title":"Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results","volume":"159","author":"Papageorgiou","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0700","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1524-4725.2000.00085.x","article-title":"Non-invasive photorejuvenation of photodamaged skin using serial, full face intense pulsed light treatments","volume":"26","author":"Bitter","year":"2000","journal-title":"Dermatol Surg"},{"issue":"Suppl","key":"10.1016\/j.abd.2020.08.001_bib0705","first-page":"17","article-title":"Effect of pulsed dye laser and intense pulsed light source on the dermal extracellular matrix remodelling","volume":"12","author":"Zelickson","year":"2000","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.abd.2020.08.001_bib0710","first-page":"21","article-title":"Devices and topical agents for rosacea management","volume":"94","author":"Mansouri","year":"2014","journal-title":"Cutis"},{"key":"10.1016\/j.abd.2020.08.001_bib0715","first-page":"725","article-title":"Diagnosis and treatment of rosacea: state of the art","volume":"11","author":"Baldwin","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0720","first-page":"557","article-title":"The pulse-dyed laser for the treatment of cutaneous conditions","volume":"144","author":"Bernstein","year":"2009","journal-title":"G Ital Dermatol Venerol"},{"key":"10.1016\/j.abd.2020.08.001_bib0725","first-page":"681","article-title":"Treatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura threshold","volume":"29","author":"Alam","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0730","first-page":"65","article-title":"Multiplex 595nm, 1064nm laser treatment for blebbed port wine birthmarks and telangiectasia","volume":"38","author":"Tanghetti","year":"2006","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.abd.2020.08.001_bib0735","first-page":"56","article-title":"Millisecond 1064-nm neodymium:YAG laser treatment of facial telangiectases","volume":"29","author":"Sarradet","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0740","first-page":"16","article-title":"Treatment outcomes of long-pulsed nd: yag laser for two different subtypes of ros\u00e1cea","volume":"8","author":"Say","year":"2015","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0745","doi-asserted-by":"crossref","first-page":"607","DOI":"10.5021\/ad.2016.28.5.607","article-title":"Prospective comparison of dual wavelength long-pulsed 755-nm Alexandrite\/1,064-nm neodymium: yttrium-aluminum-garnet laser versus 585-nm pulsed dye laser treatment for rosacea","volume":"28","author":"Seo","year":"2016","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0750","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/14764172.2017.1279334","article-title":"A case report of combination treatment with potassium-titanyl phosphate laser and brimonidinetopical gel in erythematotelangiectatic rosacea","volume":"19","author":"Hofmann","year":"2017","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.abd.2020.08.001_bib0755","first-page":"45","article-title":"Long pulsed 532-nm laser treatment of facial telangiectasias","volume":"10","author":"Tanghetti","year":"1998","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.abd.2020.08.001_bib0760","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1524-4725.1998.tb04140.x","article-title":"Comparison of the long-pulse dye (590-595nm) and KTP (532nm) lasers in the treatment of facial and leg telangiectasias","volume":"24","author":"West","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0765","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2004.03.033","article-title":"Rosacea: II. Therapy","volume":"51","author":"Pelle","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0770","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2004-822963","article-title":"Use of the KTP laser in the treatment of rosacea and solar lentigines","volume":"20","author":"Bassichis","year":"2004","journal-title":"Facial Plast Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0775","first-page":"441","article-title":"A split-face comparison study of pulsed 532-nm KTP laser and 595-nm pulsed dye laser in the treatment of facial telangiectasias and diffuse telangiectatic facial erythema","volume":"33","author":"Uebelhoer","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0780","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10103-018-2606-6","article-title":"Treatment of erythematotelangiectatic rosacea, facial erythema, and facial telangiectasia with a 577-nm pro-yellow laser: a case series","volume":"34","author":"Kapicioglu","year":"2019","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.abd.2020.08.001_bib0785","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/exd.13133","article-title":"Light-emitting diodes downregulate cathelicidin, kallikrein and toll-like receptor 2 expressions in keratinocytes and rosacea-like mouse skin","volume":"25","author":"Lee","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0790","first-page":"21","article-title":"Phototherapy with light emitting diodes: treating a broad range of medical and aesthetic conditions in dermatology","volume":"11","author":"Ablon","year":"2018","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0795","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5978\/islsm.16.97","article-title":"The photobiological basics behind light-emitting diode (LED) phototherapy","volume":"16","author":"Calderhead","year":"2007","journal-title":"Laser Ther"},{"key":"10.1016\/j.abd.2020.08.001_bib0800","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1574-695X.2003.tb00644.x","article-title":"Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light","volume":"35","author":"Ashkenazi","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.abd.2020.08.001_bib0805","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/09546630500283664","article-title":"An open study to determine the efficacy of blue light in the treatment of mild to moderate acne","volume":"16","author":"Morton","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.abd.2020.08.001_bib0810","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14764170600607624","article-title":"Light-emitting diode 415nm in the treatment of inflammatory acne: an open-label, multicentric, pilot investigation","volume":"8","author":"Tremblay","year":"2006","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.abd.2020.08.001_bib0815","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1365-2133.2000.03481.x","article-title":"Phototherapy with blue (415nm) and red (660nm) light in the treatment of acne vulgaris","volume":"142","author":"Papageorgiou","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0820","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/14764170600735912","article-title":"Combination blue (415nm) and red (633nm) LED phototherapy in the treatment of mild to severe acne vulgaris","volume":"8","author":"Goldberg","year":"2006","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.abd.2020.08.001_bib0825","series-title":"Dermatology research focus on acne","article-title":"Shedding light on acne: from myth to science (laser and light therapy for acne)","author":"Lee","year":"2009"},{"key":"10.1016\/j.abd.2020.08.001_bib0830","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/lsm.20412","article-title":"Blue and red light combination LED phototherapy for acne vulgaris in patients with skin phototype IV","volume":"39","author":"Lee","year":"2007","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.abd.2020.08.001_bib0835","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/DSS.0000000000000968","article-title":"Comparative Efficacy of Radiofrequency and Pulsed Dye Laser in the Treatment of Rosacea","volume":"43","author":"Kim","year":"2017","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0840","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/JCAS.JCAS_16_18","article-title":"Management of rhinophyma with radio frequency: case series of three patients","volume":"12","author":"Tambe","year":"2019","journal-title":"J Cutan Aesthet Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0845","first-page":"522","article-title":"Safety and effectiveness of microfocused ultrasound for treating erythematotelangiectatic rosacea","volume":"18","author":"Schlessinger","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0850","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/DSS.0000000000001552","article-title":"Dual-Frequency ultrasound as a new treatment modality for refractory rosacea: a retrospective study","volume":"44","author":"Park","year":"2018","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0855","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/lsm.23023","article-title":"The toxic edge \u2013 a novel treatment for refractory erythema and flushing of rosacea","volume":"51","author":"Friedman","year":"2019","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.abd.2020.08.001_bib0860","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ejps.2013.03.019","article-title":"Next generation intra- and transdermal therapeutic systems: using non- and minimally-invasive technologies to increase drug delivery into and across the skin","volume":"50","author":"Gratieri","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.abd.2020.08.001_bib0865","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/lsm.22227","article-title":"Laser assisted drug delivery: a review of an evolving technology","author":"Sklar","year":"2014","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.abd.2020.08.001_bib0870","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/DSS.0000000000001248","article-title":"Microneedling: a review and practical guide","volume":"44","author":"Alster","year":"2018","journal-title":"Dermatologic Surgery"},{"key":"10.1016\/j.abd.2020.08.001_bib0875","first-page":"125","article-title":"Intense pulsed light alone versus intense pulsed light and aminolevulinic acid in the treatment of photodamaged skin: importance of long term follow-up","volume":"1","author":"Issa","year":"2009","journal-title":"Surg Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0880","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/jocd.12231","article-title":"Multiple sequential light and laser sources to activate aminolevulinic acid for rosacea","volume":"15","author":"Friedmann","year":"2016","journal-title":"J Cosmetic Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0885","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1468-3083.2007.02219.x","article-title":"Photodynamic therapy in a series of rosacea patients","volume":"21","author":"Bryld","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib0890","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000086443","article-title":"Photodynamic therapy in the treatment of rosacea","volume":"211","author":"Nybaek","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.abd.2020.08.001_bib0895","first-page":"368","article-title":"Rhinophyma: practical and safe treatment with trichloroacetic acid","volume":"6","author":"Gaspar","year":"2014","journal-title":"Surg Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0900","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00006534-200209010-00023","article-title":"Rhinophyma: review and update","volume":"110","author":"Rohrich","year":"2002","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0905","first-page":"201","article-title":"Rhinophyma and coexisting occult skin cancers","volume":"27","author":"Lutz","year":"2001","journal-title":"Dermatol. Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0910","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-0032-1309304","article-title":"Nuances in the management of rhinophyma","volume":"28","author":"Little","year":"2012","journal-title":"Facial Plastic Surgery"},{"key":"10.1016\/j.abd.2020.08.001_bib0915","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1749-4486.2010.02094.x","article-title":"Surgical management of rhinophyma","volume":"35","author":"Greaney","year":"2010","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.abd.2020.08.001_bib0920","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00006534-200209010-00023","article-title":"Rhinophyma: review and update","volume":"110","author":"Rohrich","year":"2002","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0925","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/SAP.0b013e31815f12d2","article-title":"Rhinophyma: diagnosis and treatment options for a disfiguring tumor of the nose","volume":"61","author":"Sadick","year":"2008","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0930","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00266-012-0055-3","article-title":"Management of severe rhinophyma with sculpting surgical decortication","volume":"37","author":"Husein-ElAhmed","year":"2013","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0935","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jcms.2012.11.009","article-title":"Surgical correction of rhinophyma: comparison of two methods in a 15-year-long experience","volume":"41","author":"Lazzeri","year":"2013","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0940","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/dsu.12193","article-title":"Treatment of severe rhinophyma using scalpel excision and wire loop tip electrosurgery","volume":"39","author":"Prado","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0945","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1308\/rcsann.2009.91.2.167a","article-title":"\u201cA close shave\u201d \u2013 use of a disposable razor blade in the management of rhinophyma","volume":"91","author":"Fishman","year":"2009","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.abd.2020.08.001_bib0950","first-page":"91","article-title":"Application of the argon beam coagulator in plastic surgery","volume":"5","author":"Teimourian","year":"1991","journal-title":"Perspect Plast Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0955","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/archfaci.2009.34","article-title":"Sculpting resection of rhinophyma using the Shaw scalpel","volume":"11","author":"Vural","year":"2009","journal-title":"Arch Facial Plast Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0960","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/lsm.1112","article-title":"Treatment of rhinophyma with Er:YAG laser","volume":"29","author":"Orenstein","year":"2001","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.abd.2020.08.001_bib0965","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/jocd.12048","article-title":"Department of Dermatology and Venereology, Faculty of Medicine, Ain Shams University, Cairo","volume":"12","author":"Salem","year":"2013","journal-title":"Egypt. J Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0970","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/dth.12205","article-title":"Fractionated carbon dioxide laser therapy as treatment of mild rhinophyma: report of three cases","volume":"28","author":"Meesters","year":"2015","journal-title":"Dermatologic Therapy"},{"key":"10.1016\/j.abd.2020.08.001_bib0975","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s00266-004-0012-x","article-title":"The gold standard for decortication of rhinophyma: combined erbium-YAG\/CO2 laser","volume":"28","author":"Goon","year":"2004","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib0980","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/jocd.12252","article-title":"Microdermabrasion: a clinical, histometric, and histopathologic study","volume":"15","author":"El-Domyati","year":"2016","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0985","first-page":"418","article-title":"An alternative micrographic method for decreasing bleeding and recurrence in the treatment of rhinophyma","volume":"16","author":"Cemal","year":"2012","journal-title":"Eur Rer Med Pharmacol Sci"},{"key":"10.1016\/j.abd.2020.08.001_bib0990","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00128071-200506020-00003","article-title":"Microdermabrasion","volume":"6","author":"Spencer","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib0995","first-page":"809","article-title":"Microdermabrasion: reappraisal and brief review of literature","volume":"32","author":"Bhalla","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib1000","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/17469872.2013.836845","article-title":"Minimally invasive facial rejuvenation","volume":"8","author":"El-Domyati","year":"2013","journal-title":"Expert Rev Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1005","first-page":"191","article-title":"Microdermabrasion in cosmetic dermatology: a clinical study","volume":"19","author":"Badawi","year":"2006","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1010","article-title":"Fractionated carbon dioxide laser resurfacing as an ideal treatment option for severe rhinophyma: a case report and discussion","volume":"12","author":"Comeau","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1015","first-page":"28","article-title":"Dermoquimioabras\u00e3o: um tratamento eficaz e seguro para o rinofima","volume":"8","author":"Vasconcelos","year":"2016","journal-title":"Surg Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1020","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.joms.2008.01.036","article-title":"Surgical removal of rhinophyma","volume":"66","author":"Zide","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib1025","first-page":"549","article-title":"A pilot, double-blind, placebo-controlled study to assess the efficacy and safety of Incobotulinumtoxin A injections in the treatment of rosacea","volume":"16","author":"Dayan","year":"2017","journal-title":"J Drugs Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.abd.2020.08.001_bib1030","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/DSS.0000000000000277","article-title":"Impact of intradermal AbobotulinumtoxinA on facial erythema of rosacea","volume":"41","author":"Bloom","year":"2015","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib1035","first-page":"1536","article-title":"Successful use of botulinum toxin A for the treatment of neck and anterior chest wall flushing","volume":"32","author":"Alexandroff","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib1040","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1046\/j.1365-2230.2003.01379.x","article-title":"Successful use of Botulinum toxin-A for the treatment of neck and anterior chest wall flushing","volume":"28","author":"Sterodimas","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1045","first-page":"102","article-title":"Botulinum toxin for the treatment of facial flushing","volume":"30","author":"Yuraitis","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib1050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000452341","article-title":"Botulinum toxin off-label use in dermatology: a review","volume":"3","author":"Campanati","year":"2017","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.abd.2020.08.001_bib1055","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archderm.140.11.1351","article-title":"Effect of volume and concentration on the diffusion of botulinum exotoxin A","volume":"140","author":"Hsu","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1060","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/DSS.0000000000001819","article-title":"Assessment of skin physiology change and safety after intradermal injections with botulinum toxin: a randomized, double-blind, placebo-controlled, split-face pilot study in rosacea patients with facial erythema","volume":"45","author":"Kim","year":"2019","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib1065","first-page":"121","article-title":"Prospective study for the treatment of rosacea flushing with botulinum toxin type A","volume":"10","author":"Silva","year":"2018","journal-title":"Surg Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4236\/jcdsa.2012.21005","article-title":"The effect of Mesobotox together with intense pulsed light on facial wrinkles and erythema","volume":"2","author":"Bedewi","year":"2012","journal-title":"JCDSA"},{"key":"10.1016\/j.abd.2020.08.001_bib1075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1473-2165.2008.00361.x","article-title":"Different formulations of botulinum toxin type A have different migration characteristics: a double-blind, randomized study","volume":"7","author":"Cliff","year":"2008","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1524-4725.2006.32330.x","article-title":"Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis","volume":"33","author":"Trindade de Almeida","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib1085","first-page":"36","article-title":"Tratamento de ros\u00e1cea com toxina botul\u00ednica","volume":"10","author":"Antonio","year":"2018","journal-title":"Surg Cosmet Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00042728-200504000-00023","article-title":"Re: botulinum toxin for the treatment of facial flushing","volume":"31","author":"Kranendonk","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib1095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/jdv.13341","article-title":"Quality of life among patients with rosacea: an investigation of patients in China using two structured questionnaires","volume":"30","author":"Li","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2020.08.001_bib1100","doi-asserted-by":"crossref","first-page":"e0192487","DOI":"10.1371\/journal.pone.0192487","article-title":"The Rosacea-specific Quality-of-Life instrument (RosQol): revision and validation among Chinese patients","volume":"13","author":"Deng","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.abd.2020.08.001_bib1105","doi-asserted-by":"crossref","unstructured":"Oussedik E, Bourcier M, Tan J. Psychosocial Burden and Other Impacts of Rosacea on Patients\u2019 Quality of Life. Dermatol Clin. 2018;36:103\u201313.","DOI":"10.1016\/j.det.2017.11.005"},{"key":"10.1016\/j.abd.2020.08.001_bib1110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaad.2007.01.048","article-title":"A pilot quality-of-life instrument for acne rosacea","volume":"57","author":"Nicholson","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1115","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1590\/abd1806-4841.20187192","article-title":"Rosacea-specific Quality of Life Questionnaire (RosaQol): translation, cultural adaptation and validation into Brazilian-Portuguese language","volume":"93","author":"Tannus","year":"2018","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.det.2017.11.006","article-title":"Rosacea Comorbidities","volume":"36","author":"Vera","year":"2018","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2020.08.001_bib1125","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/ijd.14353","article-title":"Systemic comorbidities associated with rosacea: a multicentric retrospective observational study","volume":"58","author":"Aksoy","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaad.2015.04.028","article-title":"Cardiovascular comorbidities in patients with rosacea: a nationwide case-control study from Taiwan","volume":"73","author":"Hua","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1135","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ana.24645","article-title":"Patients with rosacea have increased risk of dementia","volume":"79","author":"Egeberg","year":"2016","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.abd.2020.08.001_bib1140","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamaneurol.2016.0022","article-title":"Exploring the association between rosacea and Parkinson disease: a Danish nationwide cohort study","volume":"73","author":"Egeberg","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.abd.2020.08.001_bib1145","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jaad.2017.09.016","article-title":"Comorbidities in rosacea: a systematic review and update","volume":"78","author":"Haber","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1150","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jaad.2016.08.055","article-title":"Prevalence and risk of migraine in patients with rosacea: a population-based cohort study","volume":"76","author":"Egeberg","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1155","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2015.5549","article-title":"Association of rosacea with risk for glioma in a Danish nationwide cohort study","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1160","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1016\/S1470-2045(16)00082-6","article-title":"Link between rosacea and glioma in nationwide cohort","volume":"17","author":"Bagcchi","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.abd.2020.08.001_bib1165","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaad.2017.06.150","article-title":"Rosacea comorbidities and future research: the 2017 update by the National Rosacea Society Expert Committee","volume":"78","author":"Gallo","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1170","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/1346-8138.14705","article-title":"Risk of psychiatric disorders in rosacea: a nationwide, population-based, cohort study in Taiwan","volume":"46","author":"Hung","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1175","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MIB.0000000000000644","article-title":"Rosacea in patients with ulcerative colitis and Crohn's disease: a population-based case-control study","volume":"22","author":"Spoendlin","year":"2016","journal-title":"Inflamm. Bowel Dis"},{"key":"10.1016\/j.abd.2020.08.001_bib1180","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaad.2016.11.065","article-title":"Risk of inflammatory bowel disease in patients with rosacea: results from a nationwide cohort study in Taiwan","volume":"76","author":"Wu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1185","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaad.2017.08.027","article-title":"Prevalence of gastrointestinal comorbidities in rosacea: comparison of subantimicrobial, modified release doxycycline versus conventional release doxycycline","volume":"78","author":"Lim","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canep.2017.01.006","article-title":"Rosacea and risk of cancer in Denmark","volume":"47","author":"Egeberg","year":"2017","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.abd.2020.08.001_bib1195","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/bjc.2015.217","article-title":"Personal history of rosacea and risk of incident cancer among women in the US","volume":"113","author":"Li","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.abd.2020.08.001_bib1200","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jaad.2019.01.013","article-title":"Rosacea: relative risk versus absolute risk of malignant comorbidities","volume":"81","author":"Tjahjono","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1205","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2017.09.004","article-title":"Frontal fibrosing alopecia and cutaneous comorbidities: a potential relationship with rosacea","volume":"78","author":"Pindado-Ortega","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1210","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaad.2015.11.004","article-title":"Clustering of autoimmune diseases in patients with ros\u00e1cea","volume":"74","author":"Egeberg","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1215","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaad.2017.07.055","article-title":"Evidence-based update on rosacea comorbidities and their common physiologic pathways","volume":"78","author":"Holmes","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/1346-8138.14689","article-title":"Association between rosacea severity and relative muscle mass: a cross-sectional study","volume":"46","author":"Nam","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1225","first-page":"6","article-title":"Informe de Consenso Ibero-Latinoamericano 2016 sobre la clasificaci\u00f3n cl\u00ednica y terap\u00e9utica de la ros\u00e1cea","volume":"44","author":"Kaminsky","year":"2016","journal-title":"Med Cutan Iber Lat Am"},{"key":"10.1016\/j.abd.2020.08.001_bib1230","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/1203475416650427","article-title":"Canadian Clinical Practice Guidelines for Rosacea","volume":"20","author":"Asai","year":"2016","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.abd.2020.08.001_bib1235","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bjd.15173","article-title":"Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel","volume":"176","author":"Schaller","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2020.08.001_bib1240","first-page":"17","article-title":"Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS)","volume":"12","author":"Del Rosso","year":"2019","journal-title":"J Clin Aesthet Dermatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059620302543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059620302543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:39:55Z","timestamp":1759793995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059620302543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":248,"alternative-id":["S0365059620302543"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2020.08.001","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus on the therapeutic management of rosacea \u2013 Brazilian Society of Dermatology","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2020.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}